U
Ufuk Abacioglu
Researcher at Marmara University
Publications - 72
Citations - 5094
Ufuk Abacioglu is an academic researcher from Marmara University. The author has contributed to research in topics: Radiation therapy & Radiosurgery. The author has an hindex of 24, co-authored 69 publications receiving 4387 citations. Previous affiliations of Ufuk Abacioglu include Hacettepe University.
Papers
More filters
Journal ArticleDOI
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher,Riccardo Soffietti,Ufuk Abacioglu,Salvador Villà,François Fauchon,Brigitta G. Baumert,L. Fariselli,Tzahala Tzuk-Shina,Rolf-Dieter Kortmann,Christian Carrie,Mohamed Ben Hassel,Mauri Kouri,Egils Valeinis,Dirk van den Berge,Sandra Collette,Laurence Collette,Rolf-Peter Mueller +16 more
TL;DR: After radiosurgery or surgery of a limited number of brain metastases, adjuvant WBRT reduces intracranial relapses and neurologic deaths but fails to improve the duration of functional independence and overall survival.
Journal ArticleDOI
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmström,Bjørn Henning Grønberg,Christine Marosi,Roger Stupp,Didier Frappaz,Henrik Schultz,Ufuk Abacioglu,Björn Tavelin,Benoit Lhermitte,Monika E. Hegi,Johan Rosell,Roger Henriksson +11 more
TL;DR: A randomised trial to assess the optimum palliative treatment in patients aged 60 years and older with glioblastoma found survival was better with temozolomide and with hypofractionated radiotherapy than with standard radiotherapy and methylated and unmethylated MGMT promoter treated with radiotherapy.
Journal ArticleDOI
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
Riccardo Soffietti,Martin Kocher,Ufuk Abacioglu,Salvador Villà,François Fauchon,Brigitta G. Baumert,L. Fariselli,Tzahala Tzuk-Shina,Rolf-Dieter Kortmann,Christian Carrie,Mohamed Ben Hassel,Mauri Kouri,Egils Valeinis,Dirk van den Berge,Rolf P. Mueller,Gloria Tridello,Laurence Collette,Andrew Bottomley +17 more
TL;DR: This study shows that adjuvant WBRT after surgery or radiosurgery of a limited number of brain metastases from solid tumors may negatively impact some aspects of HRQOL, even if these effects are transitory.
Journal ArticleDOI
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
Riccardo Soffietti,Ufuk Abacioglu,Brigitta G. Baumert,Stephanie E. Combs,Sara Kinhult,Johan M. Kros,Christine Marosi,Philippe Metellus,Alexander Radbruch,Salvador Villà Freixa,Michael Brada,Carmine M. Carapella,Matthias Preusser,Emilie Le Rhun,Roberta Rudà,Joerg C. Tonn,Damien C. Weber,Michael Weller +17 more
TL;DR: These guidelines are presented, which provide a consensus review of evidence and recommendations for diagnosis by neuroimaging and neuropathology, staging, prognostic factors, and different treatment options for patients with brain metastases from solid tumors.
Journal ArticleDOI
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
Khê Hoang-Xuan,E M Bessell,Jacoline E C Bromberg,Andreas F. Hottinger,Matthias Preusser,Roberta Rudà,Uwe Schlegel,Tali Siegal,Carole Soussain,Carole Soussain,Ufuk Abacioglu,Nathalie Cassoux,Martina Deckert,Clemens M F Dirven,Andrés J.M. Ferreri,Francesc Graus,Roger Henriksson,Ulrich Herrlinger,Martin J.B. Taphoorn,Riccardo Soffietti,Michael Weller +20 more
TL;DR: These guidelines provide consensus considerations and recommendations for diagnosis, assessment, staging, and treatment of primary CNS lymphoma and should aid clinicians in their daily practice and decision making, and serve as a basis for future investigations in neuro-oncology.